{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:10:55Z","timestamp":1792800655164,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Children's Hospital of Fudan University","award":["EK112520180204"],"award-info":[{"award-number":["EK112520180204"]}],"id":[{"id":"https:\/\/ror.org\/05n13be63","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary adrenal insufficiency (PAI) is life-threatening, and a definitive aetiological diagnosis is essential for management and prognostication. We conducted this study to investigate the genetic aetiologies of PAI in South China and explore their clinical features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seventy children were enrolled in this cross-sectional study. Clinical information was collected, and combined genetic tests were performed according to the children\u2019s manifestations. Statistical analysis was performed among the different groups. In silico or in vitro experiments were applied to determine the pathogenicity of novel variants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 70 children, 84.3% (59\/70) were diagnosed with congenital adrenal hyperplasia (CAH), and 21-hydroxylase deficiency (21-OHD) was genetically confirmed in 91.5% of these cases. Salt wasting (SW), simple virilization (SV), and non-classic (NC) CAH accounted for 66.1% (39\/59), 30.5% (18\/59), and 3.4% (2\/59) of the cases, respectively. The 17-hydroxyprogesterone (17-OHP) and testosterone (TES) levels were significantly higher in children with SW than with SV. The 17-OHP and cortisol levels in female SW patients were significantly higher than those in males. The 17-OHP, cortisol, dehydroepiandrosterone (DHEAS) and TES levels in female SW patients were significantly higher than those in female SV patients. Additionally, 72.7% (8\/11) of uncharacterized PAI patients had positive genetic findings. Among all the patients, two novel variants in the\n                      <jats:italic>CYP21A2<\/jats:italic>\n                      gene (c.833dupT and c.651\u2009+\u20092T\u2009&gt;\u2009G) were found. A microdeletion (Xp21.2\u201321.3) and five novel variants, including 2 in the\n                      <jats:italic>NR0B1<\/jats:italic>\n                      gene (c.323\u2013324CG\u2009&gt;\u2009GA and c.1231_1234delCTCA), 2 in the\n                      <jats:italic>AAAS<\/jats:italic>\n                      gene (c.399\u2009+\u20091G\u2009&gt;\u2009A and c.250delT) and 1 in the\n                      <jats:italic>NNT<\/jats:italic>\n                      gene (c.2274delT), were detected. The novel variant c.399\u2009+\u20091G\u2009&gt;\u2009A in the\n                      <jats:italic>AAAS<\/jats:italic>\n                      gene was further confirmed to lead to exon 4 skipping during mRNA transcription and produce a truncated ALADIN protein.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We found ethnicity-based differences in the\n                      <jats:italic>CYP21A2<\/jats:italic>\n                      gene variant spectrum among different study populations. Female 21-OHD patients tended to have higher 17-OHP and TES levels, which warrants caution in relation to the effects of virilization. Novel gene variants detected in the\n                      <jats:italic>CYP21A2<\/jats:italic>\n                      ,\n                      <jats:italic>NR0B1<\/jats:italic>\n                      ,\n                      <jats:italic>AAAS<\/jats:italic>\n                      and\n                      <jats:italic>NNT<\/jats:italic>\n                      genes expanded the genetic spectrum of PAI, however, further improvement of genetic testing tools beyond our protocol are still needed to uncover the complete aetiology of PAI in children.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-021-01021-x","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T04:02:55Z","timestamp":1625025775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Genetic aetiology of primary adrenal insufficiency in Chinese children"],"prefix":"10.1186","volume":"14","author":[{"given":"Zhuo","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuhui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwen","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoqian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangqian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6433-7994","authenticated-orcid":false,"given":"Feihong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"issue":"3","key":"1021_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ando.2018.03.016","volume":"79","author":"F Roucher-Boulez","year":"2018","unstructured":"Roucher-Boulez F, Mallet-Motak D, Tardy-Guidollet V, Menassa R, Goursaud C, Plotton I, et al. News about the genetics of congenital primary adrenal insufficiency. Ann Endocrinol (Paris). 2018;79(3):174\u201381.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6","key":"1021_CR2","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1210\/jc.2004-0016","volume":"90","author":"R Perry","year":"2005","unstructured":"Perry R, Kecha O, Paquette J, Huot C, Van Vliet G, Deal C. Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital. Montreal J Clin Endocrinol Metab. 2005;90(6):3243\u201350.","journal-title":"Montreal J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"1021_CR3","first-page":"9","volume":"9","author":"T Guran","year":"2017","unstructured":"Guran T. Latest insights on the etiology and management of primary adrenal insufficiency in children. J Clin Res Pediatr Endocrinol. 2017;9(Suppl 2):9\u201322.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"25","key":"1021_CR4","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJM199612193352503","volume":"335","author":"HS Bose","year":"1996","unstructured":"Bose HS, Sugawara T, Strauss JR, Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med. 1996;335(25):1870\u20138.","journal-title":"N Engl J Med"},{"issue":"4","key":"1021_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3109\/07435808609035453","volume":"12","author":"MI New","year":"1986","unstructured":"New MI. Molecular genetics and the characterization of steroid 21-hydroxylase deficiency. Endocr Res. 1986;12(4):505\u201322.","journal-title":"Endocr Res"},{"issue":"8","key":"1021_CR6","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1210\/jc.2006-0603","volume":"91","author":"L Lin","year":"2006","unstructured":"Lin L, Gu WX, Ozisik G, To WS, Owen CJ, Jameson JL, et al. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years\u2019 experience. J Clin Endocrinol Metab. 2006;91(8):3048\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1021_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/ng.2275","volume":"44","author":"VA Arboleda","year":"2012","unstructured":"Arboleda VA, Lee H, Parnaik R, Fleming A, Banerjee A, Ferraz-de-Souza B, et al. Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome. Nat Genet. 2012;44(7):788\u201392.","journal-title":"Nat Genet"},{"issue":"7","key":"1021_CR8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/ng.3569","volume":"48","author":"S Narumi","year":"2016","unstructured":"Narumi S, Amano N, Ishii T, Katsumata N, Muroya K, Adachi M, et al. SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7. Nat Genet. 2016;48(7):792\u20137.","journal-title":"Nat Genet"},{"issue":"4","key":"1021_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/hmg\/3.4.585","volume":"3","author":"A Weber","year":"1994","unstructured":"Weber A, Clark AJ. Mutations of the ACTH receptor gene are only one cause of familial glucocorticoid deficiency. Hum Mol Genet. 1994;3(4):585\u20138.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1021_CR10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng1501","volume":"37","author":"LA Metherell","year":"2005","unstructured":"Metherell LA, Chapple JP, Cooray S, David A, Becker C, Ruschendorf F, et al. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet. 2005;37(2):166\u201370.","journal-title":"Nat Genet"},{"issue":"3","key":"1021_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/hmg\/10.3.283","volume":"10","author":"K Handschug","year":"2001","unstructured":"Handschug K, Sperling S, Yoon SJ, Hennig S, Clark AJ, Huebner A. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet. 2001;10(3):283\u201390.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"1021_CR12","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ng.2299","volume":"44","author":"E Meimaridou","year":"2012","unstructured":"Meimaridou E, Kowalczyk J, Guasti L, Hughes CR, Wagner F, Frommolt P, et al. Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency. Nat Genet. 2012;44(7):740\u20132.","journal-title":"Nat Genet"},{"issue":"8","key":"1021_CR13","doi-asserted-by":"publisher","first-page":"E1556","DOI":"10.1210\/jc.2013-3844","volume":"99","author":"R Prasad","year":"2014","unstructured":"Prasad R, Chan LF, Hughes CR, Kaski JP, Kowalczyk JC, Savage MO, et al. Thioredoxin Reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD). J Clin Endocrinol Metab. 2014;99(8):E1556\u201363.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1021_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/hmg\/3.2.265","volume":"3","author":"J Mosser","year":"1994","unstructured":"Mosser J, Lutz Y, Stoeckel ME, Sarde CO, Kretz C, Douar AM, et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet. 1994;3(2):265\u201371.","journal-title":"Hum Mol Genet"},{"issue":"15","key":"1021_CR15","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.1073\/pnas.95.15.8630","volume":"95","author":"BV Geisbrecht","year":"1998","unstructured":"Geisbrecht BV, Collins CS, Reuber BE, Gould SJ. Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. Proc Natl Acad Sci U S A. 1998;95(15):8630\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1021_CR16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ymgme.2011.12.008","volume":"105","author":"T Fasano","year":"2012","unstructured":"Fasano T, Pisciotta L, Bocchi L, Guardamagna O, Assandro P, Rabacchi C, et al. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. Mol Genet Metab. 2012;105(3):450\u20136.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1021_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1530\/EJE-17-0027","volume":"177","author":"N Amano","year":"2017","unstructured":"Amano N, Narumi S, Hayashi M, Takagi M, Imai K, Nakamura T, et al. Genetic defects in pediatric-onset adrenal insufficiency in Japan. Eur J Endocrinol. 2017;177(2):187\u201394.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1021_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000441843","volume":"85","author":"SL Tsai","year":"2016","unstructured":"Tsai SL, Green J, Metherell LA, Curtis F, Fernandez B, Healey A, et al. Primary adrenocortical insufficiency case series: genetic etiologies more common than expected. Horm Res Paediatr. 2016;85(1):35\u201342.","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"1021_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1210\/jc.2015-3250","volume":"101","author":"T Guran","year":"2016","unstructured":"Guran T, Buonocore F, Saka N, Ozbek MN, Aycan Z, Bereket A, et al. Rare causes of primary adrenal insufficiency: genetic and clinical characterization of a large nationwide cohort. J Clin Endocrinol Metab. 2016;101(1):284\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"1021_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fendo.2015.00113","volume":"6","author":"LF Chan","year":"2015","unstructured":"Chan LF, Campbell DC, Novoselova TV, Clark AJ, Metherell LA. Whole-exome sequencing in the differential diagnosis of primary adrenal insufficiency in children. Front Endocrinol (Lausanne). 2015;6:113.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1021_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.fertnstert.2018.11.007","volume":"111","author":"ML Narasimhan","year":"2019","unstructured":"Narasimhan ML, Khattab A. Genetics of congenital adrenal hyperplasia and genotype-phenotype correlation. Fertil Steril. 2019;111(1):24\u20139.","journal-title":"Fertil Steril"},{"issue":"5","key":"1021_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00431-019-03348-1","volume":"178","author":"O Eyal","year":"2019","unstructured":"Eyal O, Levin Y, Oren A, Zung A, Rachmiel M, Landau Z, et al. Adrenal crises in children with adrenal insufficiency: epidemiology and risk factors. Eur J Pediatr. 2019;178(5):731\u20138.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"1021_CR23","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1210\/jc.2018-02238","volume":"104","author":"N Settas","year":"2019","unstructured":"Settas N, Persky R, Faucz FR, Sheanon N, Voutetakis A, Lodish M, et al. SGPL1 deficiency: a rare cause of primary adrenal insufficiency. J Clin Endocrinol Metab. 2019;104(5):1484\u201390.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1021_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364\u201389.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1021_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1210\/jcem-57-2-320","volume":"57","author":"MI New","year":"1983","unstructured":"New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab. 1983;57(2):320\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1021_CR26","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2009-2631","volume":"95","author":"PW Speiser","year":"2010","unstructured":"Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(9):4133\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt A","key":"1021_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jsbmb.2016.03.035","volume":"165","author":"KK Dumic","year":"2017","unstructured":"Dumic KK, Grubic Z, Yuen T, Wilson RC, Kusec V, Barisic I, et al. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia. J Steroid Biochem Mol Biol. 2017;165(Pt A):51\u20136.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"1021_CR28","first-page":"1145","volume":"78","author":"A Wedell","year":"1994","unstructured":"Wedell A, Thilen A, Ritzen EM, Stengler B, Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab. 1994;78(5):1145\u201352.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1021_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.beem.2018.05.010","volume":"32","author":"T Kirkgoz","year":"2018","unstructured":"Kirkgoz T, Guran T. Primary adrenal insufficiency in children: diagnosis and management. Best Pract Res Clin Endocrinol Metab. 2018;32(4):397\u2013424.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10\u201311","key":"1021_CR30","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.steroids.2011.04.010","volume":"76","author":"AO Chan","year":"2011","unstructured":"Chan AO, But WM, Ng KL, Wong LM, Lam YY, Tiu SC, et al. Molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Hong Kong Chinese patients. Steroids. 2011;76(10\u201311):1057\u201362.","journal-title":"Steroids"},{"issue":"6","key":"1021_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.clinbiochem.2014.01.019","volume":"47","author":"D Ma","year":"2014","unstructured":"Ma D, Chen Y, Sun Y, Yang B, Cheng J, Huang M, et al. Molecular analysis of the CYP21A2 gene in Chinese patients with steroid 21-hydroxylase deficiency. Clin Biochem. 2014;47(6):455\u201363.","journal-title":"Clin Biochem"},{"key":"1021_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.steroids.2016.01.007","volume":"108","author":"R Wang","year":"2016","unstructured":"Wang R, Yu Y, Ye J, Han L, Qiu W, Zhang H, et al. 21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: genotype-phenotype correlation and identification of nine novel mutations. Steroids. 2016;108:47\u201355.","journal-title":"Steroids"},{"issue":"2","key":"1021_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/0300060516685204","volume":"45","author":"B Zhang","year":"2017","unstructured":"Zhang B, Lu L, Lu Z. Molecular diagnosis of Chinese patients with 21-hydroxylase deficiency and analysis of genotype-phenotype correlations. J Int Med Res. 2017;45(2):481\u201392.","journal-title":"J Int Med Res"},{"key":"1021_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2018.07.039","volume":"486","author":"L Su","year":"2018","unstructured":"Su L, Yin X, Cheng J, Cai Y, Wu D, Feng Z, et al. Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China. Clin Chim Acta. 2018;486:142\u201350.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"1021_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1365-2265.2011.04123.x","volume":"75","author":"R Marino","year":"2011","unstructured":"Marino R, Ramirez P, Galeano J, Perez GN, Rocco C, Ciaccio M, et al. Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf). 2011;75(4):427\u201335.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1021_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.gene.2012.07.027","volume":"507","author":"CI Ben","year":"2012","unstructured":"Ben CI, Riepe FG, Clauser E, Ayedi A, Makni S, Sfar MT, et al. Steroid 21-hydroxylase gene mutational spectrum in 50 Tunisian patients: characterization of three novel polymorphisms. Gene. 2012;507(1):20\u20136.","journal-title":"Gene"},{"issue":"2","key":"1021_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1530\/EJE-16-0171","volume":"175","author":"DF de Carvalho","year":"2016","unstructured":"de Carvalho DF, Miranda MC, Gomes LG, Madureira G, Marcondes JA, Billerbeck AE, et al. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction. Eur J Endocrinol. 2016;175(2):107\u201316.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1021_CR38","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s40618-015-0366-8","volume":"38","author":"I Milacic","year":"2015","unstructured":"Milacic I, Barac M, Milenkovic T, Ugrin M, Klaassen K, Skakic A, et al. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations. J Endocrinol Invest. 2015;38(11):1199\u2013210.","journal-title":"J Endocrinol Invest."},{"issue":"11","key":"1021_CR39","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1210\/me.2006-0172","volume":"20","author":"T Robins","year":"2006","unstructured":"Robins T, Carlsson J, Sunnerhagen M, Wedell A, Persson B. Molecular model of human CYP21 based on mammalian CYP2C5: structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia. Mol Endocrinol. 2006;20(11):2946\u201364.","journal-title":"Mol Endocrinol"},{"issue":"3","key":"1021_CR40","first-page":"245","volume":"21","author":"PC White","year":"2000","unstructured":"White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21(3):245\u201391.","journal-title":"Endocr Rev"},{"issue":"2","key":"1021_CR41","doi-asserted-by":"publisher","first-page":"E346","DOI":"10.1210\/jc.2012-3343","volume":"98","author":"N Krone","year":"2013","unstructured":"Krone N, Rose IT, Willis DS, Hodson J, Wild SH, Doherty EJ, et al. Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort. J Clin Endocrinol Metab. 2013;98(2):E346\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1021_CR42","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1210\/jcem.85.3.6441","volume":"85","author":"N Krone","year":"2000","unstructured":"Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab. 2000;85(3):1059\u201365.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1021_CR43","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1002\/mgg3.671","volume":"7","author":"C Xu","year":"2019","unstructured":"Xu C, Jia W, Cheng X, Ying H, Chen J, Xu J, et al. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency. Mol Genet Genomic Med. 2019;7(6):e671.","journal-title":"Mol Genet Genomic Med."},{"issue":"9","key":"1021_CR44","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1210\/en.2010-0986","volume":"152","author":"JO Scheys","year":"2011","unstructured":"Scheys JO, Heaton JH, Hammer GD. Evidence of adrenal failure in aging Dax1-deficient mice. Endocrinology. 2011;152(9):3430\u20139.","journal-title":"Endocrinology"},{"issue":"8","key":"1021_CR45","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1210\/me.2003-0159","volume":"17","author":"E Lalli","year":"2003","unstructured":"Lalli E, Sassone-Corsi P. DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol Endocrinol. 2003;17(8):1445\u201353.","journal-title":"Mol Endocrinol"},{"issue":"9","key":"1021_CR46","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.bbadis.2012.03.012","volume":"1822","author":"S Kemp","year":"2012","unstructured":"Kemp S, Berger J, Aubourg P. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta. 2012;1822(9):1465\u201374.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1021_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/jdn.10003","volume":"80","author":"BR Turk","year":"2020","unstructured":"Turk BR, Theda C, Fatemi A, Moser AB. X-linked adrenoleukodystrophy: pathology, pathophysiology, diagnostic testing, newborn screening and therapies. Int J Dev Neurosci. 2020;80(1):52\u201372.","journal-title":"Int J Dev Neurosci"},{"issue":"12","key":"1021_CR48","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ejmg.2015.11.001","volume":"58","author":"O Jazayeri","year":"2015","unstructured":"Jazayeri O, Liu X, van Diemen CC, Bakker-van WW, Sikkema-Raddatz B, Sinke RJ, et al. A novel homozygous insertion and review of published mutations in the NNT gene causing familial glucocorticoid deficiency (FGD). Eur J Med Genet. 2015;58(12):642\u20139.","journal-title":"Eur J Med Genet"},{"issue":"1","key":"1021_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1530\/EJE-16-0056","volume":"175","author":"F Roucher-Boulez","year":"2016","unstructured":"Roucher-Boulez F, Mallet-Motak D, Samara-Boustani D, Jilani H, Ladjouze A, Souchon PF, et al. NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects. Eur J Endocrinol. 2016;175(1):73\u201384.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1021_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1530\/EC-18-0281","volume":"8","author":"S Riedl","year":"2019","unstructured":"Riedl S, Rohl FW, Bonfig W, Bramswig J, Richter-Unruh A, Fricke-Otto S, et al. Genotype\/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients. Endocr Connect. 2019;8(2):86\u201394.","journal-title":"Endocr Connect"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-021-01021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-021-01021-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-021-01021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T04:07:14Z","timestamp":1625026034000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-021-01021-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1186\/s12920-021-01021-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-79349\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-45355\/v1","asserted-by":"object"}]},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,30]]},"assertion":[{"value":"17 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Children\u2019s Hospital of Fudan University. Permission to access the clinical data used in the research was provided by the Ethics Committee of the Children\u2019s Hospital of Fudan University. Written informed consent for the study was obtained from all of the patients\u2019 parents. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for the publication of personal and clinical details was obtained from all of the patients\u2019 parents. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest related to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}